Filing Details

Accession Number:
0001181431-15-007778
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-02 17:02:03
Reporting Period:
2015-06-01
Filing Date:
2015-06-02
Accepted Time:
2015-06-02 17:02:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885306 Cynosure Inc CYNO Electromedical & Electrotherapeutic Apparatus (3845) 043125110
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1345970 V Ettore Biagioni C/O Cynosure, Inc.
5 Carlisle Road
Westford MA 01886
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2015-06-01 6,000 $13.97 11,220 No 4 M Direct
Class A Common Stock Acquisiton 2015-06-01 2,000 $11.89 13,220 No 4 M Direct
Class A Common Stock Acquisiton 2015-06-01 8,000 $21.16 21,220 No 4 M Direct
Class A Common Stock Acquisiton 2015-06-01 8,000 $23.45 29,220 No 4 M Direct
Class A Common Stock Disposition 2015-06-01 24,000 $36.25 5,220 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Director Stock Option (right to buy) Disposition 2015-06-01 6,000 $0.00 6,000 $13.97
Class A Common Stock Director Stock Option (right to buy) Disposition 2015-06-01 2,000 $0.00 2,000 $11.89
Class A Common Stock Director Stock Option (right to buy) Disposition 2015-06-01 8,000 $0.00 8,000 $21.16
Class A Common Stock Director Stock Option (right to buy) Disposition 2015-06-01 8,000 $0.00 8,000 $23.45
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-05-12 No 4 M Direct
0 2021-07-27 No 4 M Direct
0 2022-05-09 No 4 M Direct
0 2023-06-24 No 4 M Direct
Footnotes
  1. The number of shares include 5,220 shares currently owned plus 6,000 shares from the exercise of stock options on June 1, 2015.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  3. The sales price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $36.00 to $36.71 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  4. The option became exercisable as to 100% of the shares on the anniversary of the 5/12/2011 grant date.
  5. The option became exercisable as to 100% of the shares on the anniversary of the 7/27/2011 grant date.
  6. The option became exercisable as to 100% of the shares on the anniversary of the 5/9/2012 grant date.
  7. The option became exercisable as to 100% of the shares on the anniversary of the 6/24/2013 grant date.